Navigation Links
GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
Date:5/22/2008

Global Pharmaceutical Company Honors Former CEO with Permanent Legacy at

Alma Mater

PHILADELPHIA, May 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced the establishment of two fellowships totaling $500,000 in honor of former Chief Executive Officer Jean-Pierre Garnier, to support students enrolled at Stanford Graduate School of Business. Dr. Garnier, who received his Masters of Business Administration from the school in 1974, retired from GSK on May 21, 2008.

Dr. Garnier served as the CEO of GSK since its creation in 2001, steering it through a complex merger and driving the development of one of the strongest new product pipelines in the industry. These funds will provide an ongoing tribute to his success as the leader of the world's second-largest research-based pharmaceutical company.

"Every successful company invests in the business to grow the bottom line," said Sir Christopher Gent, GSK Chairman. "We believe that business should also invest in something less tangible, less quantifiable, but of equal importance-building its reputation with the society it serves. GSK is pleased to honor Dr. Garnier's legacy by providing funds that will help develop the business leaders of tomorrow."

"This generous gift honors an alumnus whose leadership throughout his career has changed lives, changed organizations, and ultimately changed the world," said Robert L. Joss, Dean of the Stanford Graduate School of Business. "The fellowships being established in his honor ensure that Jean-Pierre Garnier will continue to have an impact on shaping the next generation of principled, innovative, and insightful business leaders."

Investing in the Best and Brightest

To remain competitive, Stanford Business School must attract and enroll the best and the brightest students. The school's international reputation as a leader in management education is built on the quality and diversity of its students, whose broad range of experiences and backgrounds fosters a collaborative culture. The GSK funding will provide a permanent legacy to support deserving students enrolled in programs at the school in two ways:

-- A gift of $350,000 has been allocated to establish The JP and Danyele

Garnier Fellowship Fund in the Graduate School of Business. This fund

will provide a permanent legacy from which regular income will be used

to underwrite tuition and fees of deserving candidates pursuing an MBA.

-- A gift of $150,000 has been allocated to establish The JP and Danyele

Garnier Fellowship Fund in the Graduate School of Business Summer

Institute in Entrepreneurship Program. The fund will enable Stanford

Business School to support students in a unique four-week program that

provides non-business school graduate students with a background in

business management fundamentals in finance, marketing, and accounting,

through a highly-interactive experience that also helps develop

foundational business skills, such as developing a business plan,

public speaking, and leadership.

"Not only has JP Garnier's leadership had a significant impact on GSK, it has also been felt by individuals around the world-from the establishment of the GSK African Malaria Partnership and the quest to eliminate lymphatic filariasis in the developing world, to countless community partnerships," Sir Christopher said. "JP Garnier has led GSK in its challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better, and live longer. It is our hope that the recipients of these endowments will go on to do the same in their chosen fields."

About GlaxoSmithKline

GlaxoSmithKline, one of the world's leading research-based pharmaceutical and health care companies, is committed to improving the quality of human life by enabling people to do more, feel better, and live longer.

About Stanford Graduate School of Business

The Stanford Graduate School of Business, located in northern California's Silicon Valley, enrolls approximately 740 students in the two-year full-time MBA Program, 105 candidates in the PhD Program, 56 mid-career executives in the 10-month Stanford Sloan Master's Program, and more than 2,000 participants in Executive Education programs designed to enhance executives' professional capabilities. For more information visit: http://www.gsb.stanford.edu.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IADR and GlaxoSmithKline Consumer Healthcare announce winners
2. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
3. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
4. GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
5. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
6. GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding
7. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
8. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
9. AUDIO from Medialink and GlaxoSmithKline: Get Ready to Get Moving to a New You in the New Year
10. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
11. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... Las Vegas, NV (PRWEB) , ... May 02, ... ... with Specialty Pharmacy Times, has announced a new Specialty Pharmacy Patient Satisfaction Award ... be determined based on the quarterly results from Zitter Health Insights’ Specialty Pharmacy ...
(Date:5/2/2016)... , ... May 02, 2016 ... ... report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants and ... these risks, Novus Medical Detox Center —a leading Florida-based drug treatment ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, a new company developing ... and improve the rapid diagnosis, triage and admission of patients leveraging IBM Watson’s ... mobile experience for the first time at GENBAND’s Perspectives16 conference. , TeleMedCo ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased to ... Could Transform the Pharma Landscape .” CMS recently proposed a test of alternate payment ... drugs while preserving care provided to beneficiaries. The webinar will review the details of ...
(Date:5/2/2016)... ... May 02, 2016 , ... The debilitating disease of arthritis ... With no cure, most patients must deal with prescription costs to treat arthritis over ... up to 75% savings at the pharmacy on many common prescriptions. , Arthritis , ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... , May 2, 2016  Deerfield announced ... financing of Graybug Vision, Inc. Graybug Vision is ... therapies that may transform care for ocular diseases ... Graybug Vision,s technology was first developed at Johns ... a startup venture. Graybug Vision ...
(Date:4/29/2016)... April 29, 2016  In the next ten ... shift from systems dependent on CRTs monitors to those ... modality CRT Medical monitors and will automatically sync ... host of foreseeable benefits to this technological advancement, ... modalities have to be replaced in order to ...
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
Breaking Medicine Technology: